Related Experiment Video
Updated: Dec 10, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 tetramerization: at the center of the dominant-negative effect of mutant p53
Jovanka Gencel-Augusto1,2, Guillermina Lozano1,2
1Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA.
Abstract:
The p53 tumor suppressor functions as a tetrameric transcription factor to regulate hundreds of genes-many in a tissue-specific manner. Missense mutations in cancers in the p53 DNA-binding and tetramerization domains cement the importance of these domains in tumor suppression. p53 mutants with a functional tetramerization domain form mixed tetramers, which in some cases have dominant-negative effects (DNE) that inactivate wild-type p53. DNA damage appears necessary but not sufficient for DNE, indicating that upstream signals impact DNE. Posttranslational modifications and protein-protein interactions alter p53 tetramerization affecting transcription, stability, and localization. These regulatory components limit the dominant-negative effects of mutant p53 on wild-type p53 activity. A deeper understanding of the molecular basis for DNE may drive development of drugs that release WT p53 and allow tumor suppression.
Insights
Mutant p53 proteins can inactivate normal p53 function, a process influenced by upstream signals and posttranslational modifications. Understanding this dominant-negative effect is key to developing therapies that restore tumor suppression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- The p53 tumor suppressor is a critical regulator of hundreds of genes, often in a tissue-specific manner.
- Missense mutations in cancer frequently affect the p53 DNA-binding and tetramerization domains, highlighting their importance in tumor suppression.
- Mutant p53 proteins with intact tetramerization domains can form mixed tetramers with wild-type p53, leading to dominant-negative effects (DNE).
Purpose of the Study:
- To investigate the molecular mechanisms underlying the dominant-negative effects (DNE) of mutant p53 on wild-type p53 activity.
- To explore the role of upstream signals and posttranslational modifications in modulating p53 tetramerization and DNE.
- To identify potential therapeutic targets for restoring wild-type p53 function in cancer.
Main Methods:
- Analysis of p53 tetramerization domain function in cancer mutants.
- Investigation of the impact of DNA damage and upstream signaling on p53 DNE.
- Examination of posttranslational modifications and protein-protein interactions affecting p53 tetramerization.
Main Results:
- p53 mutants with functional tetramerization domains can form mixed tetramers, exerting dominant-negative effects on wild-type p53.
- DNA damage is a necessary but insufficient condition for DNE, suggesting involvement of upstream regulatory pathways.
- Posttranslational modifications and protein interactions modulate p53 tetramerization, influencing its stability, localization, and transcriptional activity, thereby limiting DNE.
Conclusions:
- Regulatory mechanisms involving posttranslational modifications and protein interactions act as a safeguard against the complete inactivation of wild-type p53 by mutants.
- A comprehensive understanding of the molecular basis of p53 dominant-negative effects is crucial for developing novel therapeutic strategies.
- Targeting these regulatory pathways could lead to drugs that release wild-type p53, restoring its tumor suppressive functions.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Destabilization of Microtubules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

